glp-1 wegovy Novo Nordisk launches weight-loss pill in US, triggering price war | Pharmaceuticals industry Wegovy Pill Wins FDA Approval

But the drug helped

Introduction The obesity and metabolic disease epidemic continues to surge, with over 40% of U.S

Direct head-to-head comparisons have not been done

In rare cases, this can increase the risk of regurgitation and aspirationstomach contents going into the lungswhich can lead to pneumonia, prolonged hospital stay, or even intensive care

FDA enforcement actions The FDA has taken a notably aggressive stance toward online retatrutide sales

Reuters coverage: Novo Nordisk Files Patent Infringement Lawsuit At the same time, on Monday, Feburary 9, 2026, Novo Nordisk filed a patent infringement lawsuit against Hims & Hers , alleging that the telehealth companys compounded products infringe U.S